Asher Biotherapeutics has filed a notice of an exempt offering of securities to raise $55 Million in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, Asher Biotherapeutics is raising up to $54,999,990.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Craig Gibbs played a…